These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4034927)

  • 21. A comparative study of [3H]thymidine and [125I]iodo-2'-deoxyuridine uptake as indicators of in vivo cell proliferation induced by graft-versus-host reaction in the mouse.
    Spach C; Motta R
    J Immunol Methods; 1983 Feb; 57(1-3):341-51. PubMed ID: 6338125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
    Humm JL; Bagshawe KD; Sharma SK; Boxer G
    Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases.
    Sahu SK; Wen PY; Foulon CF; Nagel JS; Black PM; Adelstein SJ; Kassis AI
    J Nucl Med; 1997 Mar; 38(3):386-90. PubMed ID: 9074525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell kinetics methods for clinical use: assessment of autoradiography and 125I-iodo-deoxyuridine with mouse Ehrlich tumour.
    Jenkinson IS; Shuter BJ; Wright PN
    Cell Tissue Kinet; 1975 Jul; 8(4):307-20. PubMed ID: 1149073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.
    Begg AC
    Cell Tissue Kinet; 1977 Sep; 10(5):409-27. PubMed ID: 922795
    [No Abstract]   [Full Text] [Related]  

  • 26. The toxicity of 125I-5-iodo-2'-deoxyuridine (125IUdR) to canine tissue culture cells in vitro.
    Holmes JM
    J Comp Pathol; 1982 Jul; 92(3):445-56. PubMed ID: 7142455
    [No Abstract]   [Full Text] [Related]  

  • 27. [DNA turnover in metastasis-free organs of tumor bearing mice; influence on whole body measurements with 125I-UdR (author's transl)].
    Kronenberger PH; Tisljar-Lentulis G; Porschen W; Feinendegen LE
    Beitr Pathol; 1977 May; 160(2):154-74. PubMed ID: 889561
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of 125I-5-iodo-2'-deoxyuridine labelling on murine tumour cells.
    Bishop CJ; Sheridan JW; Donald KJ
    Br J Exp Pathol; 1981 Feb; 62(1):22-6. PubMed ID: 6784742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marked survival prolongation of mice bearing a transplantable colon adenocarcinoma by treatment with radioactive platinum-[125I]histamine complex. Preliminary report.
    Garnuszek P
    Nucl Med Rev Cent East Eur; 2004; 7(2):113-6. PubMed ID: 15968596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of (125I) iododeoxyuridine in cultured rat and human prostate: effects of insulin and testosterone.
    Donaldson LJ; Thomas GH
    J Endocrinol; 1976 Apr; 69(1):85-92. PubMed ID: 58051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
    Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
    Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical modification of 5-[125I]iodo-2'-deoxyuridine toxicity in mammalian cells in vitro.
    Walicka MA; Adelstein SJ; Kassis AI
    Int J Radiat Biol; 2001 May; 77(5):625-30. PubMed ID: 11382341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
    Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell population growth and cell loss in the MTG-B mouse mammary carcinoma.
    Clifton KH; Yatvin MB
    Cancer Res; 1970 Mar; 30(3):658-64. PubMed ID: 5425291
    [No Abstract]   [Full Text] [Related]  

  • 35. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-[125]iodo-2'-deoxyuridine in the radiotherapy of solid CNS tumors in rats.
    Kassis AI; Adelstein SJ
    Acta Oncol; 1996; 35(7):935-9. PubMed ID: 9004774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.
    Makrigiorgos GM; Kassis AI; Baranowska-Kortylewicz J; McElvany KD; Welch MJ; Sastry KS; Adelstein SJ
    Radiat Res; 1989 Jun; 118(3):532-44. PubMed ID: 2727274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
    Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.
    Kassis AI; Wen PY; Van den Abbeele AD; Baranowska-Kortylewicz J; Makrigiorgos GM; Metz KR; Matalka KZ; Cook CU; Sahu SK; Black PM; Adelstein SJ
    J Nucl Med; 1998 Jul; 39(7):1148-54. PubMed ID: 9669385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles.
    Rao DV; Narra VR; Howell RW; Govelitz GF; Sastry KS
    Lancet; 1989 Sep; 2(8664):650-3. PubMed ID: 2570902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.